New Risk • May 14
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 10.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (25% accrual ratio). Market cap is less than US$10m (₹433.7m market cap, or US$4.53m). Minor Risk Share price has been volatile over the past 3 months (10.0% average weekly change). Reported Earnings • May 14
Full year 2026 earnings released: EPS: ₹3.21 (vs ₹1.86 in FY 2025) Full year 2026 results: EPS: ₹3.21 (up from ₹1.86 in FY 2025). Revenue: ₹1.50b (up 12% from FY 2025). Net income: ₹32.5m (up 72% from FY 2025). Profit margin: 2.2% (up from 1.4% in FY 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 23% per year whereas the company’s share price has increased by 21% per year. Valuation Update With 7 Day Price Move • May 13
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to ₹35.40, the stock trades at a trailing P/E ratio of 22.8x. Average trailing P/E is 22x in the Chemicals industry in India. Total returns to shareholders of 42% over the past three years. Aankondiging • May 07
Camex Limited to Report Q4, 2026 Results on May 12, 2026 Camex Limited announced that they will report Q4, 2026 results on May 12, 2026 Reported Earnings • Feb 06
Third quarter 2026 earnings released: EPS: ₹0.80 (vs ₹0.31 loss in 3Q 2025) Third quarter 2026 results: EPS: ₹0.80 (up from ₹0.31 loss in 3Q 2025). Revenue: ₹366.9m (up 30% from 3Q 2025). Net income: ₹8.18m (up ₹11.4m from 3Q 2025). Profit margin: 2.2% (up from net loss in 3Q 2025). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth. Aankondiging • Feb 02
Camex Limited to Report Q3, 2026 Results on Feb 05, 2026 Camex Limited announced that they will report Q3, 2026 results on Feb 05, 2026 Reported Earnings • Nov 14
Second quarter 2026 earnings released: ₹0.27 loss per share (vs ₹1.43 profit in 2Q 2025) Second quarter 2026 results: ₹0.27 loss per share (down from ₹1.43 profit in 2Q 2025). Revenue: ₹373.0m (up 8.4% from 2Q 2025). Net loss: ₹2.79m (down 119% from profit in 2Q 2025). Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth. Aankondiging • Nov 05
Camex Limited to Report Q2, 2026 Results on Nov 12, 2025 Camex Limited announced that they will report Q2, 2026 results at 12:15 PM, Indian Standard Time on Nov 12, 2025 Reported Earnings • Aug 14
First quarter 2026 earnings released: EPS: ₹0.85 (vs ₹0.60 in 1Q 2025) First quarter 2026 results: EPS: ₹0.85 (up from ₹0.60 in 1Q 2025). Revenue: ₹344.6m (up 1.8% from 1Q 2025). Net income: ₹8.99m (up 48% from 1Q 2025). Profit margin: 2.6% (up from 1.8% in 1Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 15% per year whereas the company’s share price has increased by 14% per year. Reported Earnings • Jul 12
Full year 2025 earnings released: EPS: ₹1.86 (vs ₹3.39 in FY 2024) Full year 2025 results: EPS: ₹1.86 (down from ₹3.39 in FY 2024). Revenue: ₹1.34b (down 5.8% from FY 2024). Net income: ₹18.9m (down 45% from FY 2024). Profit margin: 1.4% (down from 2.4% in FY 2024). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 12% per year whereas the company’s share price has increased by 15% per year. Aankondiging • Jul 08
Camex Limited, Annual General Meeting, Aug 05, 2025 Camex Limited, Annual General Meeting, Aug 05, 2025, at 12:30 Indian Standard Time. Reported Earnings • May 16
Full year 2025 earnings released: EPS: ₹1.83 (vs ₹3.39 in FY 2024) Full year 2025 results: EPS: ₹1.83 (down from ₹3.39 in FY 2024). Revenue: ₹1.34b (down 5.2% from FY 2024). Net income: ₹18.7m (down 46% from FY 2024). Profit margin: 1.4% (down from 2.4% in FY 2024). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 12% per year and the company’s share price has also increased by 12% per year. Aankondiging • May 12
Camex Limited to Report Q4, 2025 Results on May 15, 2025 Camex Limited announced that they will report Q4, 2025 results on May 15, 2025 Board Change • Apr 03
Less than half of directors are independent There are 4 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 4 new directors. No experienced directors. 1 highly experienced director. 2 independent directors (3 non-independent directors). Chairman & MD Chandraprakash Chopra is the most experienced director on the board, commencing their role in 1992. Additional Independent Non-Executive Director Uttam Bhandari was the last independent director to join the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors. Aankondiging • Apr 02
Camex Limited Announces Resignation of Arpit Shah as an Independent Director, Effective April 1, 2025 Camex Limited announced that Mr. Arpit Shah has resigned as an independent director of the company due to his pre-occupation and other professional commitments and consequently he ceased to be a director of the company with effect from the close of business hours on April 1, 2025. Names of listed entities in which the resigning director holds directorships, indicating the category of directorship and membership of board committees, if any: Directorship in Listed Companies: AVI POLYMERS LIMITED; Committee Position: AVI POLYMERS LIMITED; Audit Committee – Member; Nomination and Remuneration Committee – Member; CSR Committee – Member. New Risk • Feb 14
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (₹406.1m market cap, or US$4.67m). Minor Risk Share price has been volatile over the past 3 months (7.7% average weekly change). Valuation Update With 7 Day Price Move • Feb 13
Investor sentiment deteriorates as stock falls 24% After last week's 24% share price decline to ₹39.78, the stock trades at a trailing P/E ratio of 12.3x. Average trailing P/E is 27x in the Chemicals industry in India. Total returns to shareholders of 20% over the past three years. Reported Earnings • Feb 06
Third quarter 2025 earnings released: ₹0.31 loss per share (vs ₹1.14 profit in 3Q 2024) Third quarter 2025 results: ₹0.31 loss per share (down from ₹1.14 profit in 3Q 2024). Revenue: ₹282.1m (down 18% from 3Q 2024). Net loss: ₹3.19m (down 127% from profit in 3Q 2024). Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth. Aankondiging • Jan 22
Camex Limited to Report Q3, 2025 Results on Feb 03, 2025 Camex Limited announced that they will report Q3, 2025 results on Feb 03, 2025 Reported Earnings • Nov 01
Second quarter 2025 earnings released: EPS: ₹1.43 (vs ₹0.97 in 2Q 2024) Second quarter 2025 results: EPS: ₹1.43 (up from ₹0.97 in 2Q 2024). Revenue: ₹343.9m (down 2.3% from 2Q 2024). Net income: ₹14.6m (up 47% from 2Q 2024). Profit margin: 4.2% (up from 2.8% in 2Q 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 24% per year and the company’s share price has also increased by 24% per year. Aankondiging • Oct 19
Camex Limited to Report Q2, 2025 Results on Oct 28, 2024 Camex Limited announced that they will report Q2, 2025 results on Oct 28, 2024 Reported Earnings • Aug 01
Full year 2024 earnings released: EPS: ₹3.39 (vs ₹0.014 loss in FY 2023) Full year 2024 results: EPS: ₹3.39 (up from ₹0.014 loss in FY 2023). Revenue: ₹1.42b (down 3.4% from FY 2023). Net income: ₹34.6m (up ₹34.8m from FY 2023). Profit margin: 2.4% (up from 0% in FY 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has increased by 27% per year, which means it is tracking significantly ahead of earnings growth. Aankondiging • Jul 30
Camex Limited, Annual General Meeting, Aug 21, 2024 Camex Limited, Annual General Meeting, Aug 21, 2024, at 14:00 Indian Standard Time. Aankondiging • Jul 27
Camex Limited to Report Q1, 2025 Results on Aug 06, 2024 Camex Limited announced that they will report Q1, 2025 results on Aug 06, 2024 Valuation Update With 7 Day Price Move • Jun 26
Investor sentiment improves as stock rises 26% After last week's 26% share price gain to ₹66.10, the stock trades at a trailing P/E ratio of 19.6x. Average trailing P/E is 34x in the Chemicals industry in India. Total returns to shareholders of 120% over the past three years. Valuation Update With 7 Day Price Move • May 21
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₹49.15, the stock trades at a trailing P/E ratio of 26.4x. Average trailing P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 36% over the past three years. Aankondiging • May 11
Camex Limited to Report Q4, 2024 Results on May 17, 2024 Camex Limited announced that they will report Q4, 2024 results on May 17, 2024 New Risk • Feb 05
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended March 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.5% average weekly change). Earnings have declined by 11% per year over the past 5 years. Market cap is less than US$10m (₹418.9m market cap, or US$5.05m). Minor Risk Latest financial reports are more than 6 months old (reported March 2023 fiscal period end). Aankondiging • Jan 31
Camex Limited to Report Q3, 2024 Results on Feb 07, 2024 Camex Limited announced that they will report Q3, 2024 results on Feb 07, 2024 New Risk • Dec 11
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 11% per year over the past 5 years. Market cap is less than US$10m (₹358.0m market cap, or US$4.29m). Minor Risk Share price has been volatile over the past 3 months (7.2% average weekly change). Aankondiging • Oct 14
Camex Limited to Report Q2, 2024 Results on Oct 20, 2023 Camex Limited announced that they will report Q2, 2024 results on Oct 20, 2023 Aankondiging • Jul 29
Camex Limited to Report Q1, 2024 Results on Aug 08, 2023 Camex Limited announced that they will report Q1, 2024 results on Aug 08, 2023 Reported Earnings • Jul 26
Full year 2023 earnings released: ₹0.014 loss per share (vs ₹3.08 profit in FY 2022) Full year 2023 results: ₹0.014 loss per share (down from ₹3.08 profit in FY 2022). Revenue: ₹1.47b (down 18% from FY 2022). Net loss: ₹142.0k (down 100% from profit in FY 2022). Profit margin: 0% (down from 1.8% in FY 2022). Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has only increased by 28% per year, which means it is significantly lagging earnings growth. Aankondiging • Jul 12
Camex Limited, Annual General Meeting, Aug 18, 2023 Camex Limited, Annual General Meeting, Aug 18, 2023. Reported Earnings • May 31
Full year 2023 earnings released: ₹0.30 loss per share (vs ₹3.08 profit in FY 2022) Full year 2023 results: ₹0.30 loss per share (down from ₹3.08 profit in FY 2022). Revenue: ₹1.48b (down 17% from FY 2022). Net loss: ₹142.0k (down 100% from profit in FY 2022). Profit margin: 0% (down from 1.8% in FY 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has only increased by 26% per year, which means it is significantly lagging earnings growth. Aankondiging • May 23
Camex Limited to Report Q4, 2023 Results on May 29, 2023 Camex Limited announced that they will report Q4, 2023 results on May 29, 2023 Reported Earnings • Feb 02
Third quarter 2023 earnings released: ₹0.52 loss per share (vs ₹1.35 profit in 3Q 2022) Third quarter 2023 results: ₹0.52 loss per share (down from ₹1.35 profit in 3Q 2022). Revenue: ₹306.3m (down 42% from 3Q 2022). Net loss: ₹4.86m (down 135% from profit in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 43% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth. Aankondiging • Jan 26
Camex Limited to Report Q3, 2023 Results on Feb 01, 2023 Camex Limited announced that they will report Q3, 2023 results on Feb 01, 2023 Aankondiging • Nov 24
Camex Limited Announces Executive Changes Camex Limited announced that Mr. Vishal Vadhvana, an Associate Member of the Institute of company Secretaries of India, be and is hereby appointed, as the Company Secretary of the Company with effect from November 14, 2022, to perform the duties of a Company Secretary as required under the companies act, 2013 and any other duties assigned by the Board of Directors from time to time subject to Review as may be decided by the Board of Directors from time to time. Mr. Vishal Chandrakant Vadhvana, an Associate Member of the Institute of Company Secretaries of India, be and is hereby appointed the compliance officer of the company as per regulation 6 of the SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015. Aankondiging • Nov 15
Camex Limited Appoints Vishal Vadhvana as Company Secretary and Compliance Officer Camex Limited at its board meeting to be held on November 14,2022, approved the appointment of Mr. Vishal Vadhvana as a Company Secretary and Compliance officer of the Company effective November 14, 2022. Valuation Update With 7 Day Price Move • Oct 12
Investor sentiment improved over the past week After last week's 15% share price gain to ₹33.20, the stock trades at a trailing P/E ratio of 9.1x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 50% over the past three years. Recent Insider Transactions • Sep 12
Insider recently sold ₹283k worth of stock On the 9th of September, Devendra Chopra sold around 10k shares on-market at roughly ₹29.69 per share. This transaction amounted to 16% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of ₹11m more than they bought in the last 12 months. Aankondiging • Sep 08
Camex Limited Announces Resignation of Kruti Shah as Company Secretary and Compliance 0Fficer Camex Limited announced that Ms. Kruti Shah has tendered her resignation from the post of Company Secretary and Compliance 0fficer of the Company with immediate effect from September 7, 2022. Aankondiging • Aug 28
Camex Approves Appointment of Rahul Chopra as Non-Executive Director Camex Limited at the AGM held on August 27, 2022 approved appointment of Mr. Rahul Chopra (DIN: 02724914) as a Non-executive Director of the Company. Reported Earnings • Aug 15
First quarter 2023 earnings released: EPS: ₹0.04 (vs ₹0.53 loss in 1Q 2022) First quarter 2023 results: EPS: ₹0.04 (up from ₹0.53 loss in 1Q 2022). Revenue: ₹449.1m (up 21% from 1Q 2022). Net income: ₹420.0k (up ₹5.79m from 1Q 2022). Profit margin: 0.1% (up from net loss in 1Q 2022). Over the last 3 years on average, earnings per share has increased by 1% per year whereas the company’s share price has increased by 5% per year. Aankondiging • Aug 03
Camex Limited to Report Q1, 2023 Results on Aug 09, 2022 Camex Limited announced that they will report Q1, 2023 results on Aug 09, 2022 Aankondiging • Aug 02
Camex Limited, Annual General Meeting, Aug 27, 2022 Camex Limited, Annual General Meeting, Aug 27, 2022, at 13:00 Indian Standard Time. Valuation Update With 7 Day Price Move • Jun 03
Investor sentiment improved over the past week After last week's 15% share price gain to ₹29.40, the stock trades at a trailing P/E ratio of 19.3x. Average trailing P/E is 17x in the Chemicals industry in India. Negligible returns to shareholders over past three years. Aankondiging • May 24
Camex Limited to Report Q4, 2022 Results on May 30, 2022 Camex Limited announced that they will report Q4, 2022 results on May 30, 2022 Board Change • Apr 27
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 2 highly experienced directors. Non-Executive Independent Director Arpit Shah was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • Apr 07
Investor sentiment improved over the past week After last week's 15% share price gain to ₹29.95, the stock trades at a trailing P/E ratio of 19.6x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 1.3% over the past three years. Recent Insider Transactions • Mar 21
Insider recently sold ₹507k worth of stock On the 17th of March, Devendra Chopra sold around 18k shares on-market at roughly ₹27.85 per share. In the last 3 months, they made an even bigger sale worth ₹5.1m. Insiders have been net sellers, collectively disposing of ₹10m more than they bought in the last 12 months. Recent Insider Transactions • Mar 15
Insider recently sold ₹481k worth of stock On the 11th of March, Devendra Chopra sold around 16k shares on-market at roughly ₹29.49 per share. In the last 3 months, they made an even bigger sale worth ₹5.1m. Insiders have been net sellers, collectively disposing of ₹10m more than they bought in the last 12 months. Valuation Update With 7 Day Price Move • Feb 14
Investor sentiment deteriorated over the past week After last week's 19% share price decline to ₹31.55, the stock trades at a trailing P/E ratio of 20.7x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 15% over the past three years. Recent Insider Transactions • Feb 06
Insider recently sold ₹4.7m worth of stock On the 3rd of February, Devendra Chopra sold around 138k shares on-market at roughly ₹34.45 per share. This was the largest sale by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months. Reported Earnings • Feb 05
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Third quarter 2022 results: EPS: ₹1.35 (up from ₹0.92 in 3Q 2021). Revenue: ₹533.4m (up 11% from 3Q 2021). Net income: ₹13.8m (up 46% from 3Q 2021). Profit margin: 2.6% (up from 2.0% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 54% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Jan 03
Investor sentiment improved over the past week After last week's 24% share price gain to ₹33.85, the stock trades at a trailing P/E ratio of 30.7x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 12% over the past three years. Reported Earnings • Nov 03
Second quarter 2022 earnings released: EPS ₹0.25 (vs ₹0.18 in 2Q 2021) The company reported a decent second quarter result with improved earnings and profit margins, although revenues were weaker. Second quarter 2022 results: Revenue: ₹340.9m (down 7.1% from 2Q 2021). Net income: ₹2.59m (up 43% from 2Q 2021). Profit margin: 0.8% (up from 0.5% in 2Q 2021). The increase in margin was driven by lower expenses. Valuation Update With 7 Day Price Move • Oct 05
Investor sentiment improved over the past week After last week's 17% share price gain to ₹32.10, the stock trades at a trailing P/E ratio of 31.3x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 2.7% over the past three years. Board Change • Sep 02
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 1 highly experienced director. Non-Executive Independent Director Arpit Shah was the last director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Valuation Update With 7 Day Price Move • Aug 23
Investor sentiment deteriorated over the past week After last week's 16% share price decline to ₹22.70, the stock trades at a trailing P/E ratio of 21.5x. Average trailing P/E is 17x in the Chemicals industry in India. Total loss to shareholders of 41% over the past three years. Reported Earnings • Jul 25
First quarter 2022 earnings released: ₹0.53 loss per share (vs ₹0.22 loss in 1Q 2021) The company reported a solid first quarter result with improved revenues and control over costs, although losses increased. First quarter 2022 results: Revenue: ₹371.3m (up 163% from 1Q 2021). Net loss: ₹5.37m (loss widened 140% from 1Q 2021). Reported Earnings • Jun 07
Full year 2021 earnings released: EPS ₹1.37 (vs ₹1.23 in FY 2020) The company reported a solid full year result with improved earnings and revenues, although profit margins were weaker. Full year 2021 results: Revenue: ₹1.51b (up 14% from FY 2020). Net income: ₹13.6m (up 8.4% from FY 2020). Profit margin: 0.9% (down from 1.0% in FY 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 52% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • May 12
Investor sentiment improved over the past week After last week's 31% share price gain to ₹30.25, the stock trades at a trailing P/E ratio of 31.3x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 4.7% over the past three years. Valuation Update With 7 Day Price Move • Apr 24
Investor sentiment improved over the past week After last week's 47% share price gain to ₹26.40, the stock trades at a trailing P/E ratio of 27.3x. Average trailing P/E is 17x in the Chemicals industry in India. Total loss to shareholders of 22% over the past three years. Is New 90 Day High Low • Mar 14
New 90-day high: ₹21.00 The company is up 4.0% from its price of ₹20.15 on 14 December 2020. The Indian market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 10.0% over the same period. Reported Earnings • Feb 04
Third quarter 2021 earnings released: EPS ₹0.92 (vs ₹0.08 in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₹482.9m (up 63% from 3Q 2020). Net income: ₹9.42m (up ₹8.57m from 3Q 2020). Profit margin: 2.0% (up from 0.3% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 59% per year but the company’s share price has only fallen by 22% per year, which means it has not declined as severely as earnings. Aankondiging • Jan 26
Camex Limited to Report Q3, 2021 Results on Feb 02, 2021 Camex Limited announced that they will report Q3, 2021 results on Feb 02, 2021 Aankondiging • Dec 18
Camex Limited Announces Demise of Mahaveer Chopra, Whole-Time Director Camex Limited announced sudden and sad demise of Mr. Mahaveer Chopra, Whole-time Director of the Company on December 15, 2020. Is New 90 Day High Low • Dec 03
New 90-day high: ₹18.40 The company is up 20% from its price of ₹15.35 on 04 September 2020. The Indian market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 12% over the same period. Reported Earnings • Nov 08
Second quarter 2021 earnings released: EPS ₹0.18 The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: ₹367.4m (up 16% from 2Q 2020). Net income: ₹1.81m (up 86% from 2Q 2020). Profit margin: 0.5% (up from 0.3% in 2Q 2020). The increase in margin was driven by higher revenue. Aankondiging • Aug 22
Camex Limited to Report Q1, 2020 Results on Aug 29, 2020 Camex Limited announced that they will report Q1, 2020 results on Aug 29, 2020 Aankondiging • Jul 23
Camex Limited to Report Q4, 2020 Results on Jul 30, 2020 Camex Limited announced that they will report Q4, 2020 results on Jul 30, 2020 
